Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Kelli N Burger"'
Autor:
Emmalee J Northrop-Albrecht, Chung Wah Wu, Calise K Berger, William R Taylor, Patrick H Foote, Karen A Doering, Anna M Gonser, Aditya Bhagwate, Zhifu Sun, Douglas W Mahoney, Kelli N Burger, Lisa A Boardman, John B Kisiel
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0308711 (2024)
Regular screening for colorectal cancer (CRC) is critical for early detection and long-term survival. Despite the current screening options available and advancements in therapies there will be around 53,000 CRC related deaths this year. There is gre
Externí odkaz:
https://doaj.org/article/6d7a94ddfe824517a2e217f4cc9f03f0
Autor:
Shounak Majumder, Thorvardur R. Halfdanarson, Calise K. Berger, Patrick H. Foote, Xiaoming Cao, Maria C. McGlinch, Brianna J. Gysbers, Jaime de La Fuente, Mariah J. Robran, Karen A. Doering, Kelli N. Burger, William E. Bamlet, Ann L. Oberg, Douglas W. Mahoney, Rondell P. Graham, William R. Taylor, Gloria M. Petersen, John B. Kisiel
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 3, Pp 409-416 (2022)
Background and Aims: Methylated DNA markers (MDMs) accurately identify several different cancer types, but there are limited data for pancreatic neuroendocrine tumors (pNETs). We aimed to identify MDM candidates in tissue that differentiate pNETs fro
Externí odkaz:
https://doaj.org/article/90339e48a18143f3be865fc2ccd81cc1
Autor:
Derek W. Ebner, Jason D. Eckmann, Kelli N. Burger, Douglas W. Mahoney, Thomas J. Whitaker, Ivy A. Petersen, John B. Kisiel
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 5, Pp 746-754 (2022)
Background and Aims: Multitarget stool DNA (mt-sDNA) is approved for average-risk colorectal cancer screening; test performance in persons with prior radiation therapy (RT) has not been studied. RT can induce gastrointestinal bleeding and alter DNA m
Externí odkaz:
https://doaj.org/article/bcf2291e38ed4f89830a58e69d17e50d
Autor:
Jamie N. Bakkum-Gamez, Mark E. Sherman, Seth W. Slettedahl, Douglas W. Mahoney, Maureen A. Lemens, Shannon K. Laughlin-Tommaso, Matthew R. Hopkins, Ann VanOosten, Viji Shridhar, Julie K. Staub, Xiaoming Cao, Patrick H. Foote, Megan A. Clarke, Kelli N. Burger, Calise K. Berger, Maria C. O'Connell, Karen A. Doering, Karl C. Podratz, Christopher C. DeStephano, J. Kenneth Schoolmeester, Sarah E. Kerr, Nicolas Wentzensen, William R. Taylor, John B. Kisiel
Publikováno v:
Gynecologic Oncology. 174:11-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e0ab19ab28286a3b564c48aedc1d49f
https://doi.org/10.1016/j.ygyno.2023.04.014
https://doi.org/10.1016/j.ygyno.2023.04.014
Autor:
Karthik V. Giridhar, Fergus J. Couch, Jason P. Sinnwell, Seth W. Slettedahl, William R. Taylor, Douglas W. Mahoney, Patrick H. Foote, Maria C. O’Connell, Mariah J. Robran, Mary E. Devens, Anna M. Gonser, Nicole Larson, Karen A. Doering, Kelli N. Burger, Michael Kaiser, Hatim Allawi, Kathryn Ruddy, Janet Olson, John B. Kisiel
Publikováno v:
Cancer Research. 83:P2-11
Objective: Aberrantly methylated DNA may be used to detect minimal residual disease or early recurrence in breast cancer. As a 1st step, we aimed to develop an MDM panel to delineate between healthy women, stage I-III breast cancer in remission with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b43a809c977dd9875037102fa5588834
https://doi.org/10.1158/1538-7445.sabcs22-p2-11-06
https://doi.org/10.1158/1538-7445.sabcs22-p2-11-06
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplemental Figure 3 shows the distributions in plasma from controls and PDAC patients by stage of disease and standardized copy numbers of all MDMs other than HOXA1 and PRKCB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a717d799158338ead95fc1b4cf073db
https://doi.org/10.1158/1078-0432.22483674
https://doi.org/10.1158/1078-0432.22483674
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 1 Baseline characteristics of patients in Primary and Metastatic Tissue MDM Concordance Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6140eadd916a8d5b2bed2b2dd65a56
https://doi.org/10.1158/1078-0432.22478361.v1
https://doi.org/10.1158/1078-0432.22478361.v1
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplementary Tables and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2910971755fc70ffb556e609909e8e
https://doi.org/10.1158/1078-0432.22483671
https://doi.org/10.1158/1078-0432.22483671
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 1: The average level of all MDMs assayed from DNA extracted from primary and metastatic CRC tissues was not significantly different in Primary and Metastatic Tissue MDM Concordance Study. (A) Average level of all MDMs in metachron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa55c1af0d1fd3996e00f0184447d94
https://doi.org/10.1158/1078-0432.22478376
https://doi.org/10.1158/1078-0432.22478376
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Purpose:We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case–control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC.Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfe6d10f173d139a456cd7a066ad01c
https://doi.org/10.1158/1078-0432.c.6531204.v1
https://doi.org/10.1158/1078-0432.c.6531204.v1